ARG42163
anti-YIPF3 antibody
anti-YIPF3 antibody for Western blot and Mouse
Overview
Product Description | Rabbit Polyclonal antibody recognizes YIPF3 |
---|---|
Tested Reactivity | Ms |
Tested Application | WB |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | IgG |
Target Name | YIPF3 |
Antigen Species | Human |
Immunogen | KLH-conjugated synthetic peptide between aa. 292-321 of Human YIPF3. |
Conjugation | Un-conjugated |
Alternate Names | Natural killer cell-specific antigen KLIP1; C6orf109; Protein YIPF3; YIP1 family member 3; FinGER3; dJ337H4.3; Killer lineage protein 1; KLIP1 |
Application Instructions
Application Suggestion |
|
||||
---|---|---|---|---|---|
Application Note | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. | ||||
Positive Control | Mouse liver | ||||
Observed Size | ~ 34 kDa |
Properties
Form | Liquid |
---|---|
Purification | Purification with Protein A and immunogen peptide. |
Buffer | PBS and 0.09% (W/V) Sodium azide. |
Preservative | 0.09% (W/V) Sodium azide |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Database Links | |
---|---|
Gene Symbol | YIPF3 |
Gene Full Name | Yip1 domain family, member 3 |
Function | Involved in the maintenance of the Golgi structure. May play a role in hematopoiesis. [UniProt] |
Cellular Localization | Cell membrane; Multi-pass membrane protein. Cytoplasm. Golgi apparatus, cis-Golgi network membrane; Multi-pass membrane protein. Note=Localization to the cytoplasm or to the cell membrane is developmentally and ontogenetically regulated. [UniProt] |
Calculated MW | 38 kDa |
PTM | N-glycosylated in the ER (40 kDa form I), then O-glycosylated in the Golgi apparatus (46 kDa form II), the C-terminal lumenal region is later removed in the Golgi apparatus to produce a 36 kDa form III. O-glycosylated with core 1-like and core 2-like glycans. O-glycan heterogeneity at Thr-346: HexNAc (minor), HexHexNAc (major), Hex1HexNAc2 (minor), Hex2HexNAc2 (minor) and dHex1Hex2HexNAc2 (minor). [UniProt] |
Images (1) Click the Picture to Zoom In